Pharmacogenetics of the anti-HCV drug sofosbuvir: a preliminary study

Abstract Background Sofosbuvir is a potent nucleotide HCV NS5B polymerase inhibitor that is also a P-glycoprotein (encoded by the ABCB1 gene) and breast cancer resistance protein (encoded by the ABCG2 gene) substrate. Concerning previous anti-HCV therapies, pharmacogenetics had a significant impact,...

Full description

Saved in:
Bibliographic Details
Published inJournal of antimicrobial chemotherapy Vol. 73; no. 6; pp. 1659 - 1664
Main Authors Cusato, Jessica, De Nicolò, Amedeo, Boglione, Lucio, Favata, Fabio, Ariaudo, Alessandra, Mornese Pinna, Simone, Carcieri, Chiara, Guido, Federica, Avataneo, Valeria, Cariti, Giuseppe, Di Perri, Giovanni, D’Avolio, Antonio
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.06.2018
Online AccessGet full text

Cover

Loading…